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Abstract: Management and prognosis of diseases requires the measurement in non- or minimally
invasively collected samples of specific circulating biomarkers, consisting of any measurable or
observable factors in patients that indicate normal or disease-related biological processes or responses
to therapy. Therefore, on-site, fast and accurate determination of these low abundance circulating
biomarkers in scarcely treated body fluids is of great interest for health monitoring and biological
applications. In this field, electrochemical DNA sensors (or genosensors) have demonstrated to
be interesting alternatives to more complex conventional strategies. Currently, electrochemical
genosensors are considered very promising analytical tools for this purpose due to their fast
response, low cost, high sensitivity, compatibility with microfabrication technology and simple
operation mode which makes them compatible with point-of-care (POC) testing. In this review, the
relevance and current challenges of the determination of circulating biomarkers related to relevant
diseases (cancer, bacterial and viral infections and neurodegenerative diseases) are briefly discussed.
An overview of the electrochemical nucleic acid–based strategies developed in the last five years for
this purpose is given to show to both familiar and non-expert readers the great potential of these
methodologies for circulating biomarker determination. After highlighting the main features of the
reported electrochemical genosensing strategies through the critical discussion of selected examples,
a conclusions section points out the still existing challenges and future directions in this field.
Keywords: circulating biomarkers; electrochemical genosensors; cancer; bacterial and viral infections;
neurodegenerative diseases
1. Introduction
Early diagnosis and treatment of any disease reduces its severity and possible complications,
playing an important role in successful treatment. The presence of various disease-signaling biomarkers
in non- or minimally invasively collected biofluids accurately reflect normal and disease states in
humans. Therefore, there is a great demand for developing new strategies for the reliable detection of
circulating biomarkers due to the attractiveness of these approaches for non-invasive clinical diagnosis
and prognosis and the compatibility with point-of-care (POC) applications. These strategies should
improve clinical diagnosis, management, and treatment and accelerate decision-making in emergency
situations (through rapid determination of parameters critical in time such as cardiac markers and
blood metabolites). This demand of sensors especially tailored for the particular requirements of
real-time analysis in physiological samples has driven the development of POC tests (POCT) able to
provide non-trained personnel with clinical results within a few minutes in settings different from
those of normal healthcare services [1]. In this context, electrochemical genosensing can be considered
particularly well suited for this purpose as a consequence of its inherent high sensitivity and selectivity,
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simplicity, availability, affordable instrumentation, feasibility for miniaturization and suitability for
decentralized applications.
Electrochemical genosensing seeks to exploit the great potentiality of coupling specific and
efficient affinity reactions involving nucleic acids with electroanalytical techniques. This combination
typically allows the development of inexpensive and rapid methods to determine analytes in a highly
sensitive and selective manner, in a broad context facing a wide variety of analytical problems in
biomedical research, drug discovery, environment, food, process industries, security and defense and
particularly relevant nowadays in clinical diagnosis. Although electrochemical nucleic acid-based
sensors exploit a range of distinct chemistries, they all take advantage of the nanoscale interactions
(mainly hybridizations, ligations or conformational changes) between the target present in solution, the
recognition layer, and the electrode surface, allowing their electrochemical detection using inexpensive
analyzers [2]. As a general example, Figure 1 shows a schematic display of the main steps involved in
an electrochemical DNA sensor for the detection of a particular target using a sandwich hybridization
format and electrochemical detection (by differential pulse voltammetry) of the redox label with which
the detector probe has been conjugated. Moreover, the growing research in advanced nanomaterials
has impressively impacted also this field, by providing a large variety of novel, versatile and rationally
designed nanostructured supports for transduction, signal generation and amplification purposes [3].
Indeed, the specific and efficient interactions involved in electrochemical genosensing can be detected
by using various electrochemical strategies that exploit the redox reactions of reporters or enzymes,
direct or catalytic oxidation of nucleic acid bases and electrochemistry of nanoparticles, conducting
polymers (CPs) and quantum dots. In parallel with the major advances in nanotechnology, the wide
variety of commercially available nucleic acids conjugated on demand with a variety of tags depending
on the required needs, the versatility of design and modification offered by electrochemical substrates
and the excellent performance and variability of powerful electrochemical techniques have also played
major roles in the outstanding capabilities demonstrated by electrochemical biosensors. The aim of
this review article is to shed useful insights into the latest advances, current trends and challenges and
future prospects in the exciting field of electrochemical genosensing focused on the determination of
circulating biomarkers.
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Figure 1. Schematic display of a general nucleic acid-based sensor for the determination of a particular
target involving immobilization of a specific capture probe on the electrode surface (1); specific
hybridization of the immobilized capture probe with the target sequence (2) and of the captured
target with the label-conjugated detector probe (3) and electrochemical detection of the hybridization
reactions by differential pulse voltammetry of the label attached to the detector probe (4).
2. Circulating Biomarkers
Circulating biomarkers are biomolecules that can be objectively measured in a wide variety of
body fluids (blood, urine, saliva, amniotic fluid, breast milk, bronchoalveolar lavage, cerebro-spinal
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fluid, semen, pleural effusion, ascites, etc.) and evaluated as indicators of normal or abnormal processes
or conditions or diseases and pharmacologic responses to therapeutics [4]. Concentration levels of
these molecules are representative of changes occurring in the basic cell regulatory functions and
cellular physiology, such as cell division or contact inhibition, and may vary from their normal levels
in case of diseases and disorders [5]. Circulating biomarkers can derive from various molecular origins,
including small molecules such as glucose or cholesterol, DNAs (i.e., specific mutation, translocation,
amplification in characteristic genes such as BCRA1, KRAS, cell-free DNAs, RNAs (mRNAs and
miRNAs), proteins (i.e., hormones, antibodies, oncogenes, or tumor suppressors), exosomes and tumor
cells. These circulating biomarkers in general can be categorized into different groups according to
their potential usage [4,6]:
- Risk screening biomarkers, used to determine disease susceptibility of an individual,
- Prognostic biomarkers which provides information on the probability of the disease in
an untreated individual,
- Predictive biomarkers, particular proteins or genes indicating sensitivity or resistance to a specific
therapy, and
- Diagnostic and disease monitoring biomarkers, used to aid the diagnosis and monitoring the
progression of disease.
Since different diseases (cancer, bacterial and viral infections and neurodegenerative diseases)
are known to produce or alter circulating biomarkers levels, they have the potential to be used in
understanding the pathogenesis of disease prognosis and for diagnostic purposes, as well as in the
development of new therapeutic treatment regimens [7]. Therefore, sensitive and rapid analytical
methods are very important for the accurate determination of circulating biomarkers in liquid biopsy
samples. In order to avoid false positives and diagnostic ambiguity, which can arise from population
variations in expression of a single biomarker in certain diseases such as cancer and/or from the lack
of specificity to a particular disease of the target biomarker, simultaneous measurements of a panel of
biomarkers are typically required [5,8]. These parallel measurements of groups of biomarkers hold
enormous potential for early disease detection and personalized therapy [9].
Although genomic (e.g., DNA sequencing, PCR amplification detection, DNA microarray
assay) and proteomic (conventional enzyme linked immunosorbent assays, ELISAs) methods are
being extensively developed for circulating biomarkers determination, they currently involve
labor-intensive, high-cost, and time-consuming processes which demanded skilled people, and have
limited multiplexing capabilities, all in all significantly limiting their applications to diagnostics at
POC [6]. Therefore, there is an urgent need to develop portable, simple, rapid, inexpensive tools for
accurate determination of circulating biomarkers, which could be readily implemented in decentralized
and resource-limited settings to overcome the shortcomings of conventional methodologies.
3. Electrochemical Genosensing of Circulating Biomarkers
Nowadays, electrochemical nucleic acid biosensing (genosensing), based on the use of
sequence-specific probes as a biorecognition element and electrochemical transduction to convert
nucleic acid hybridization into a detectable signal, has demonstrated great promise to address the
deficiencies of conventional technologies for determination of circulating biomarkers associated with
pathogenic, genetic, emerging and infectious diseases and inheritable and non-communicable diseases
such as cancer and cardiovascular diseases [10]. Electrochemical genosensing combines the inherent
selectivity provided by sequence-specific nucleic acid hybridization or conformational change with
the unique advantages of electrochemical sensing technology, such as high sensitivity and selectivity,
low cost, easy handling, simple instrumentation, rapid responses, miniaturization ability and easy
integration into portable platforms and feasibility for multiplexing [3,6,10–14].
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Electrochemical genosensors involve the immobilization of a specific nucleic acid recognition
layer, able to recognize selectively a biomarker of genetic or protein nature, onto the electrode surface
and the examination of electrochemical response before and after the occurrence of the bioaffinity
reaction with the target analyte. Different strategies have been employed for electrochemical detection
of DNA-target analyte interaction: direct and sandwich hybridization assays using enzyme or redox
indicators as labels, assays based on DNA conformational changes and measurement of the electron
transfer variation before and after the recognition [15].
The main bioreceptors used in electrochemical genosensing of circulating biomarkers include
specific single-stranded (ss) DNA (both linear and hairpin probes) and RNA sequences, aptamers and
peptides. Aptamers are in vitro selected ss-DNA or RNA molecules capable of binding a wide range
of nucleic and non-nucleic acid molecules (proteins, viruses, bacteria or whole cells) with high affinity
and specificity [16–18]. In solution aptamers are folded into a 3D structure containing binding site for
the target. The affinity of aptamers to their targets is in the micromolar to the subnanomolar range
and can therefore be comparable and in certain cases even better than those of antibodies for the same
targets. Moreover, in comparison with antibodies, aptamers are more stable and flexible and since they
are selected in vitro their sequence can be reproduced with high accuracy. In addition, aptamers can
be chemically modified by various labels (redox, quantum dots and nanoparticles), allowing them to
be immobilized at various surfaces and developing a wide variety of assay formats and amplification
strategies [18].
Apart from these high affinity bioreceptors, the advances in the use of magnetic beads (MBs),
screen-printed electrodes (SPEs) and nanomaterials have played major roles in improving the
analytical performance of electrochemical genosensors, in their miniaturization and in their production
costs reduction.
The use of MBs substantially improved electrochemical genosensing in terms of enhanced
sensitivity, reproducibility, and reduced assay turnaround [13]. MBs provide a large surface area for
bioreceptor immobilization and bioreactions, serving as effective solid supports for the straightforward
isolation, purification, and pre-concentration of target analytes using an external magnetic field.
The MB-based genosensing approaches perform the hybridization and transduction steps on different
surfaces (the MBs and unmodified electrodes, respectively), which eliminates the major problems
associated with nonspecific adsorptions of non-target sample components, enhancing considerably the
assay specificity and sensitivity.
Low cost and mass produced SPEs have been extensively employed for developing novel
electrochemical genosensors providing advantages such as portability, miniaturization and low
sample consumption, contributing to the great potential they have in POC tests. Other interesting
characteristics of SPEs are their versatility of design which allows customizing their production and
modification for special applications and multiplexed analysis. Moreover, the planar nature of the
SPEs makes easy the modification of their surface, even in a mass-producible way using an automatic
dispenser, and their coupling with MBs to develop MBs-based electrochemical genosensors [4].
Since the performance of electrochemical genosensors depends strongly on the amount and
stability of the nucleic acid probes immobilized at the surface of the sensing device, the incorporation of
a wide variety of unique nanomaterials such as graphene, graphene oxide, mesoporous nanomaterials,
gold nanoparticles (AuNPs), gold nanorods (AuNRs) and multi-walled carbon nanotubes (MWCNTs),
with large surface area, abundant binding points, favorable catalytic activity, conductivity and
biocompatibility [19], into electrochemical genosensors has contributed to maximize their detection
capabilities. The coupling of nanomaterials with electrochemical genosensors has demonstrated to
improve the selectivity and the signal-to-noise ratios, thus increasing sensitivity and lowering the
detection limits (LODs), minimize interference from biological matrices and prolong their stability
meeting the demands for detection of extremely low concentrated circulating biomarkers [20].
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Within this interesting context, this review discusses briefly the potential of electrochemical
genosensors for the determination of circulating biomarkers and highlights some relevant approaches,
classifying them regarding the type of biomarker determined. We will focus only in methods reported
in the last five years which have been evaluated for circulating biomarkers determination in liquid
biopsy samples, in connection to diseases of great current relevance such as cancer, neurodegenerative
diseases and bacterial and viral infections. Main bottlenecks involved and possible research directions
are also pointed out.
3.1. Electrochemical Genosensing of Cancer Biomarkers
Chen et al. [21] developed a very sensitive and selective electrochemical sensor based on
nuclease-assisted target recycling and DNAzyme for determination of oral cancer overexpressed
1 (ORAOV1)-related DNA species. The authors used a thiolated signaling probe (Sp), self-assembled
together with 6-mercaptohexanol (MCH) on a gold disk electrode, which comprised a target recognition
sequence containing a nicking endonuclease recognition sequence and a G-rich sequence. The duplex
formed in the presence of the perfectly matched target was cleaved by the specific endonuclease.
The target DNA dissociated from the Sp was then able to hybridize with a new un-nicked Sp remaining
only the G-rich sequence part on the electrode surface. After completion of the strand-scission cycle
and upon addition of hemin, the G-rich sequence can form the G-quadruplex-hemin DNAzyme
and catalyze the enzymatic reduction of H2O2 mediated by 3,3′,5,5′ tetramethylbenzidine (TMB).
The as-developed amperometric genosensor showed a linear correlation with the target DNA
concentration over the 0.08–8.0 fM range, a LOD of 0.02 fM, a good discrimination against single-base
mismatches and demonstrated good results in the analysis of artificial saliva samples. A homogeneous
immobilization-free electrochemical genosensing method was developed by Tan et al. to determine
also ORAOV1-related DNA species [22]. The strategy involved the use of a methylene blue (MB)
labeled substrate strand and signal amplification of nicking endonuclease assisted target recycling at
negative charged indium-tin oxide (ITO) electrode. By measuring the reduction signal of MB using
DPV, this method detected as low as 0.35 pM of the target DNA and was applied to the analysis of
spiked saliva samples.
Wei’s group developed a multiplexed electrochemical sensor to detect mutations in the epidermal
growth factor receptor (EGFR) gene directly in saliva samples [23]. The biosensing strategy involves the
detection of the target biomarkers released from saliva by applying an electric field and using specific
sandwich hybridization assays performed onto a conducting polymer-modified electrochemical array
of 16 gold electrodes. The target DNAs were sandwiched between capture probes copolymerized with
pyrrole (Py) onto the bare gold electrodes and detector probes labeled with fluorescein isothiocyanate
(FITC). Upon incubation with an HRP-conjugated anti-FITC antibody, the hybridization efficiency
was followed by measuring the cathodic current obtained by chronoamperometry at −0.2 V vs. Au
electrodes in the presence of H2O2 and TMB. The usefulness of the multiplexed genosensing platform
was demonstrated by detecting EGFR mutations in saliva samples of patients with non-small cell lung
carcinoma (NSCLC).
A DNA sensor for BRCA1, a breast cancer-related gene detection was proposed by Rasheed et al. [12]
using a graphene oxide-modified glassy carbon electrode (GO/GCE). The method implied a sandwich
hybridization strategy using amino terminated capture and detector probes, covalently immobilized
though 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/N-hydroxysuccinimide (EDC/NHS) chemistry
on GO/CGE and O-(3-carboxypropyl)-O′-[2-(3-mercaptopropionyl-amino)ethyl]-polyethylene glycol
(CPEG)-modified AuNPs, respectively. By measuring chronoamperometrically at +1.1 V vs. SCE the
anodic current of conjugated AuNPs, a linear response was found with the logarithmic target DNA
concentration in the 1 fM to 1 nM range and a 1 fM LOD was reported.
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Pingarrón’s group [24] developed an electrochemical DNA biosensor for detection of a target
DNA sequence of the p53 tumor suppressor gene utilizing SPCEs modified with a reduced graphene
oxide-carboxymethylcellulose hybrid nanomaterial. The modified electrodes were used as covalent
immobilization platforms for a selective 33 nts DNA hairpin-forming capture probe with biotin
and amine modifications at the 5′ and 3′ ends, respectively. A streptavidin-peroxidase (Strep-HRP)
conjugate was employed as electrochemical indicator. Hybridization was monitored by amperometry
using TMB as redox mediator and H2O2 as enzyme substrate. These disposable biosensors provided
a LOD of 2.9 nM for the synthetic target without any target or signal amplification process as well as
complete discrimination towards a single base mismatch in untreated and undiluted spiked human
serum and saliva samples. The same group developed a MB-based genosensing approach for the
determination of mRNA associated to interleukin-8 (IL-8) mRNA [25]. The method was based on
the hybridization of the target biotinylated oligonucleotide onto Strep-MBs modified with a specific
biotinylated hairpin probe, labeling with a Strep-HRP polymer and amperometric detection at SPCEs
using the H2O2/hydroquinone (HQ) system. This approach showed a LOD of 0.21 nM and successful
recoveries in raw undiluted human saliva samples.
Huang et al. [26] developed an electrochemical DNA biosensor for very sensitive determination of
human papillomavirus (HPV), associated with 93–100% of worldwide invasive carcinomas [26–28], by
immobilizing a specific capture probe on a GCE modified with graphene/Au nanorods/polythionine.
A sandwich hybridization format was used for the determination of the target DNA (a 34-base fragment
specific from HPV-16 gene) by means of two auxiliary probes (AP1 and AP2) for amplification purposes
via a long-range self-assembled DNA nanostructure. The DPV signal of [Ru(phen)3]2+ intercalated
in the long dsDNA structure was used to determine the target DNA concentration. This genosensor
displayed excellent performance for HPV DNA determination with a linear range between 1.0 × 10−13
and 1.0 × 10−10 M and a LOD of 4.03 × 10−14 M and was successfully applied to the analysis of
serum samples.
MicroRNAs (miRNAs) are nowadays considered reliable non-invasive molecular biomarkers
linked to the development of human cancers, cardiovascular diseases, and viral infections.
Currently, electrochemical nucleic acid-based biosensing strategies for miRNAs determination
involving direct [29,30] or competitive [31,32] hybridization assays, the use of novel affinity biosensors
based on the specific recognition of RNA-RNA [33–36] or DNA-DNA [37,38] duplexes, and different
amplification strategies [39–45] provide attractive alternatives for their implementation in the clinical
routine able to overcome the limitations of conventional quantification strategies. Table 1 summarizes
the main characteristics of electrochemical genosensors developed and applied successfully for the
determination of cancer-related circulating miRNAs in biofluids.
3.2. Electrochemical Genosensing of Neurodegenerative Diseases Biomarkers
Miodek et al. [46] developed an electrochemical aptasensor for determination of human cellular
prions (PrPC) proteins, responsible for the transmissible spongiform encephalopathies (TSEs), a group
of fatal neurodegenerative diseases including Creutzfeldt-Jakob disease in human and spongiform
encephalopathy in animals [47]. The genosensing platform involved immobilization of a specific
biotinylated aptamer through streptavidin binding to a biotinylated scaffold. The scaffold was prepared
by covalent immobilization of polyamidoamine (PAMAM) G4 dendrimer to MWCNTs adsorbed on
the surface of a gold electrode and subsequent covalent attachment of the redox marker ferrocene (Fc)
modified with two phtalamido groups (Fc(NHP)2) to the PAMAM G4 and of biotin hydrazide on
the remaining phtalymidyl esters of the Fc moieties. The peak current values measured by cyclic
voltammetry of Fc incorporated between the dendrimer and aptamer interlayer decreased with the
PrPc concentration due to a slower electron transfer resulting from the permeability decrease of the
sensing layer after attachment of the prion proteins to the surface. The feasibility of this approach,
with a wide linear detection linear range (1 pM–10 µM) and a LOD of 0.5 pM, was demonstrated for
detection of PrPC in spiked blood plasma samples.
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Table 1. Electrochemical genosensors for determination of cancer-related circulating miRNAs.
Electrode Approach/Type of Hybridization Assay TargetmiRNA/Disease
Electrochemical
Technique/Redox Probe L.R. LOD Applicability Reference
Gold disk electrode
Immobilization of a thiolated DNA probe/Direct
competitive and complexation of the
biotin-miRNA with Fc-capped AuNPs/streptavidin
(Strep) conjugates




isothermal amplification strategy and
MBs-based enzymatic amplification
hsa-miR-200a Chronoamperometry/TMB + H2O2
1 aM–10 fM 0.22 aM Spikedsaliva samples [39]
AuNPs-modified SPCE
Immobilization of a thiolated RNA probe/Direct
hybridization (1), p. 19 binding onto the RNA-RNA
duplex formed on the electrode surface (2) and
displacement of the p19 attached to the electrode
by incubation in a mixture of a target miRNA and






10 aM–1 µM 5 aM Humanserum samples [33]
Gold disk electrode
Immobilization of a thiolated DNA probe together
with thioglycolic acid, direct hybridization and
isothermal amplification by a DSN






Immobilization of a thiolated DNA probe (probe 1),
MCH and BSA/Direct hybridization and RCA
amplification using a mixture of the target miRNA,
probe 2 (DNA added for initiation of RCA
amplification), a cyclized padlock probe and phi29
DNA polymerase
miRNA-143/Cancer Chronocoulometry/Ruhex 100 fM–1 nM 100 fM Spiked humanblood samples [41]
Gold disk electrode
Immobilization of a molecular beacon, sandwich
hybridization and mediated SDA (using Klenow
fragment (3′–5′exo) and Nb.BbvCI nicking
exonuclease) and enzymatic amplifications (Strep-AP)
miRNA-222 DPV/α-NP 50 pM–10 nM 40 pM Spiked humanserum samples [42]
Au-SPEs Immobilization of a thiolated RNA probe/Direct miRNA-155/ SWV/[Fe(CN)6]3−/4− 10 aM–1.0 nM 5.7 aM
Human
serum samples [29]
GCE functionalized with AuNRs
decorated on GO sheets Immobilization of a thiolated RNA probe/Direct miRNA-155 DPV/Oracet Blue (OB) 2.0 fM–8.0 pM 0.6 fM
Spiked human
plasma samples [30]
Magnetic-GCE DSNATR and biotinylated capture probes enrichedfrom the solution to the electrode surface using MBs miRNA-21 EIS/[Fe(CN)6]
4−/3− — 60 aM Humanserum samples [43]
GCE target recycling, nicking-replication reaction andDNAzyme catalysis coupling miRNA-21 Amperometry/TMB + H2O2 1 aM–100 pM 0.5 aM
Spiked human
serum samples [44]
Abbreviations: AuNPs: gold nanoparticles; AuNRs: gold nanorods; CV: cyclic voltammetry; DNS: duplex specific nuclease; DPV: differential pulse voltammetry; DSNATR: duplex-specific
nuclease assisted target recycling; EIS: electrochemical impedance spectroscopy; Fc: ferrocene; GO: graphene oxide; SDA: strand displacement amplification; SWV: square wave
voltammetry; TMB: 3,3′,5,5′ tetramethylbenzidine.
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An ultrasensitive electrochemical detection system using a target-responsive encapsulation assay,
graphene and mesoporous materials (MSGNs) multifunctional hybrids and ss-DNA probes as the
pore-caps was developed by Wu et al. [48]. The approach is based on the loading of electroactive
molecules (MB and Fc) on MSGNs and the locking of the pores by target-induced conformational
change of the tailored DNA caps. The specific DNA probes change their conformation closing pores
only in the presence of the target analytes and therefore provoked an increased electroanalytical
signal of the loaded electroactive molecules measured by DPV (see Figure 2). This scaffold allows the
incorporation of various redox-active molecules into the mesopores and to be modified by different
nucleic acid bioreceptors, which provides a high versatility and easy multiplexing ability to the
approach. The usefulness of the biosensor was assessed by determining DNA sequences correlated to
Alzheimer, thrombin and ATP in serum samples.
Same group developed a similar approach but using a novel ratiometric and on-off signaling
mode for detection of the mutated apolipoprotein E gene associated with Alzheimer’s disease using
graphene and mesoporous hybrid nanomaterials (GSHs)-modified GCE [49]. The GSHs, which served
as nanoreservoirs for the electro-active molecules (such as MB), were covalently conjugated with
ferrocene carboxylic acid, used as inner reference molecule for indicating the amount of GSHs used.
While in the absence of target DNA a duplex DNA probe connected to the surface of GSHs prevented
the leakage of loaded caged electrochemical reporter (MB), the presence of the target DNA induced
the nanopores opening which led to the release of MB molecules and hence to a smaller signal.
The ratiometric output signal was obtained by calculating the ratio of peak current measured by DPV
of the signal-indicator (MB) and built-in control (Fc).
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Results reported by the authors demonstrated the major role of the short DNA diluents used to prevent
surface fouling, a LOD of 1 nM and promising applicability to perform the determination of HIV
antibodies in spiked 10% saliva samples.
Oliveira et al. [51] proposed a method for the detection of DNA sequences specific of dengue
virus serotype 3 (DENV-3). In this genosensing approach, a specific 22-mer DNA probe was adsorbed
onto a pencil graphite electrode and DPV of the guanine oxidation signal was used for electrochemical
analysis. This sensor allowed achieving a linear range from 10 to 100 nM, a LOD of 3.09 nM and
selective detection of target sequences both in buffer and spiked human serum samples.
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Figure 3. Electrochemical biosensor for HIV antibodies using a specific peptide and short DNAs as
diluents. In the presence pf HIV antibodies the surface mobility of the immobilized peptide probe is
limited and the MB current measured by ACV decreased. Reprinted from [50] with permission.
ig ly se sitive i pedi etric biosensor for detecting human norovirus by assembling
a thiolated affinity peptide on a gold electrode was also develope [52]. This impedimetric genosensing
approach showed a linear quantitative response to a wide range of norovirus concentrations
(10–107 copies mL−1) and LODs of 99.8 nM for recombinant noroviral capsid proteins (rP2) and
7.8 copies mL−1 for real norovirus from diarrheal patients. Results presented demonstrated also the
feasibility of this method to perform the determination in fetal bovine serum.
3.4. Electrochemical Genosensing of Bacterial Infections Biomarkers
Wu et al. [53] achieved very sensitive chronoamperometric determination of Escherichia coli (E. coli)
by preparing a ternary surface monolayer composed of a thiolated capture probe (specific for the
E. coli 16S rRNA), MCH and dithiothreitol (DTT) onto a photolithography prepared 16-sensor Au
electrode array. Using a sandwich hybridization assay involving fluorescein (FITC)-labeled detector
probes, recognition by an HRP conjugated–anti-FITC antibody and chronoamperometric detection
with the TMB/H2O2 system, the electrochemical genosensor provided absolute LODs of 40 zmol
for the synthetic target DNA and only 1 colony forming unit (CFU) E. coli per sensor. Moreover, the
applicability and specificity of the biosensor were evaluated in the analysis of real uropathogenic
clinical isolates.
A disposable amperometric MBs-based DNA sensor coupled to asymmetric PCR (aPCR) was
developed for the detection of Streptococcus pneumoniae (S. pneumoniae) [54]. This method relied on
the selective hybridization of specific biotinylated capture DNA probe, complementary to a specific
region of the pneumococcal lytA gene. The biotinylated synthetic target or the predominantly 235-base
single-stranded (ss) amplicon generated by direct asymmetric PCR (daPCR) from bacterial cultures
were hybridized onto Strep-MBs modified with a specific biotinylated DNA probe. After labeling of the
biotinylated duplex formed at the Strep-MBs with Strep-HRP, amperometric detection was performed
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upon addition of H2O2 at tetrathiafulvalene (TTF)-Au-SPEs (Figure 4). LOD values of 5.1 and 1.1 nM
for the 20-mer synthetic target DNA and the ss-aPCR amplicon were achieved, respectively. Moreover,
daPCR amplicons could be obtained with as few as 2 CFUs of S. pneumoniae. Furthermore, this
methodology demonstrated a clear discrimination against Streptococcus mitis (a closely related
streptococcus) and between blood and urine samples non-inoculated and inoculated with the target
bacteria at a very low concentration (103 CFUs mL−1). The DNA sensor was successfully validated with
109 clinical samples of diverse origins providing both sensitivity and specificity of around 90% [55].
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Yamanaka et al. [56] designed an electrochemical strategy to quantify Porphyromonas gingivalis (Pg),
a bacterium causing periodontal disease, in saliva. The strategy was based on mixing bisbenzimidazole
trihydrochloride as electrochemical intercalator with the amplicons obtained by direct PCR (dPCR).
The indicator peak current, measured by linear sweep voltammetry (LSW), decreased in the presence
of amplicons over the 1–104 cells range due to the indicator slower diffusion after intercalation into the
amplified DNA. The results achieved in the analysis of saliva samples confirmed that the quantitative
detection of direct PCR-amplified products from Pg clearly reflect the periodontal disease degree of
and the age-dependence.
A rapid urine test for detection of urogenital Schistosomiasis was developed by Mach et al. [57].
The biosensor relied on sandwich hybridization of the Schistosoma haematobium (S. haematobium) 16S
rRNA using a specific thiolated DNA capture probe self-assembled onto a gold electrode and a detector
probe labeled with fluorescein (FITC). Upon incubation with a specific HRP conjugated–anti-FITC
antibody, the hybridization reaction was monitored by chronoamperometry in the presence of
TMB/H2O2. The DNA sensor allowed detecting 0.53 ng mL−1 total RNA isolated from S. haematobium
egg and approximately 30 S. haematobium eggs per mL of human urine.
Thiruppathiraja et al. [58] developed a sandwich-based DNA biosensor for Mycobacterium sp.
genomic DNA detection using dual labeled-AuNPs for amplification purposes. The target
DNA is sandwiched between a specific probe immobilized on a ITO electrode modified with
a (3-aminopropyl)trimethoxysilane (APTMS) SAM and the detector probes immobilized together
with the enzyme alkaline phosphatase (AP) on AuNPs (Figure 5). The electrochemical detection was
Sensors 2017, 17, 866 11 of 20
performed by DPV using p-nitrophenol phosphate as enzyme substrate. The method allowed a LOD
of 1.25 ng mL−1 genomic DNA and was successfully evaluated in clinical sputum samples.
Other electrochemical biosensor for M. tuberculosis [59] was prepared by covalent immobilization
of an amino-terminated DNA probe (specific to the rpoB gene, the gene most commonly mutated
in rifampicin resistant bacteria [60,61]) and Fc(NHP)2 onto a new composite material prepared by
electrochemical assembly of PAMAM, polypyrrole (pPy) and MWCNTs onto a gold electrode. In this
design, MWCNTs coated with pPy were prepared by wrapping the polymer film on MWCNTs during
electrochemical polymerization of Py on the gold electrode. Subsequently, the MWCNTs-pPy layer
was modified with PAMAM dendrimers of fourth generation (PAMAM G4) with covalent bonding
by electro-oxidation. The hybridization was followed by measuring SW voltammetric signals of
Fc. This biosensing strategy was shown to be suitable for the determination of amplicons obtained
from clinical samples and for discriminating single nucleotide polymorphism sequences, which are
responsible for resistance to rifampicin.
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HRP-conjugated antiFITC antibody (Figure 6). The electrochemical transduction was performed 
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Figure 5. Schematic display of the electrochemical DNA biosensor developed for Mycobacterium sp.
genomic DNA detection using a specific probe immobilized on an ITO electrode and AuNPs
modified both with detector probes and the enzyme alkaline phosphatase (AP). Reprinted from [58]
with permission.
Lobo-Castañón´s group developed also an attractive electrochemical genomagnetic approach
by combining the use of MBs and chronoamperometric detection at SPCEs with asymmetric
helicase-dependent DNA amplification (HDA) to amplify an 84-base-long ss-DNA fragment from
the insertion sequence IS6110 characteristics of M. tuberculosis [62]. The method involved the
immobilization of the biotinylated ss-amplicon onto the surface of Strep-MBs, the hybridization of the
captured amplicon with an FITC-detector probe and subsequent labeling with an HRP-conjugated
antiFITC antibody (Figure 6). The electrochemical transduction was performed upon capturing
magnetically the modified MBs onto the SPCE surface by chronoamperometry and the H2O2/TMB
system. The method allowed obtaining a linear range from 1 aM to 1 fM and LOD of 0.5 aM for the
synthetic target DNA determination in less than 4 h. A year later, same group [63] compared the
performance of this method with that achieved by using asymmetric PCR. The same dynamic range
(between 30 and 3000 copies) were obtained with both amplification strategies and similar LODs of 11
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and 15 copies (0.4 and 0.5 aM) using PCR and HAD, respectively, were found. The electrochemical
genosensor coupled with both amplification approaches demonstrated comparable and successful
results in the detection of M. tuberculosis in clinical samples (sputum, urine, and pleural fluid samples).
A microfluidic-multiplexed electrochemical platform with integrated sensors composed of CNTs
associated with Fc for direct impedimetric detection without any amplification of genomic DNA
from M. tuberculosis and pathogenic viral DNA from hepatitis C in clinical isolates was developed
by Zribi et al. [64]. The monolithic chip integrates three independent fluidic polydimethylsiloxane
channels, each containing one electrochemical chamber with three gold electrodes to perform three
independent measurements (negative control, DNA detection and DNA mismatch detection).
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EIS using Fe(CN)63−/4−, the developed sensor recognized the L. infantum genomic DNA at different 
concentrations (1–4 ng mL−1) and demonstrated applicability to the analysis of contaminated canine 
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Figure 6. Schematic representation of the steps involved in the M. tuberculosis determination using
an electrochemical genomagnetic assay coupled to HDA. The biotinylated ss-amplicon resulting from
the HDA was immobilized onto the surface of Strep-MBs and further hybridized with an FITC-detector
probe and labeled with an HRP-antiFITC antibody. Reprinted from [62] with permission.
The resulting fluidic device, due to the flo and geo etry, enhanced 50 times the capture rate
(from 0.02 to 1 DNA strand per s), six times the electron transfer rate constant (from 1 up to 6 s−1)
and decreased the LOD of the electrochemical biosensor from picomolar (2 pM) in bulk solution
to femtomolar (7 fM). In addition, it offered a large dynamic range (0.1 fM–1 pM) for a synthetic
ssDNA from Hepatitis C virus. The miniaturized microfluidic device allowed also direct detection of
M. tuberculosis (H37Rv) rpoB allele in DNA extracted from clinical isolates without PCR amplification.
García et al. developed an electroche ic l sensor for specific detecti n of Leishmania
infantum (L. infantum) genome [65]. This biosensor l ed the i mobilization of a DNA pr be onto
a gold electrode pr viously coated with a layer of ptopropyltrimethoxysilane on polyaniline
matrix containing AuNPs (PANIAuNPs) (Figure 7). By evaluating the primer-genome interaction by
EIS using Fe(CN)63−/4−, the developed sensor recognized the L. infantum genomic DNA at different
concentrations (1–4 ng mL−1) and demonstrated applicability to the analysis of contaminated canine
serum samples.
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Other interesting methodology for the determination of Leishmania DNA was developed
combining the use of isothermal recombinase polymerase amplification (RPA), primers labeled with
MBs and AuNPs and electrochemical detection at SPCEs (Figure 8) [66]. After magnetic capture
of the double-labeled amplified product (MB/amplified DNA/AuNP complex) onto the SPCE,
the chronoamperometric measurement of the electrocatalytic activity of the AuNPs towards the
hydrogen evolution reaction allowed the determination of the amplicons. This method exhibited
a linear relationship between the measures current and the logarithm of parasite concentration in the
range between 0.5 and 500 parasites per mL of blood, a LOD of 0.8 parasites per mL of blood and
perfect discrimination between blood samples from healthy and infected dogs.
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4. General Considerations
This review article sheds useful insights into the latest advances, current trends and prospects
in the electrochemical genosensing of circulating biomarkers. The highlighted methods have been
developed for the determination of circulating biomarkers associated with cancer (mutations in the
EGFR and p53 genes, DNA species related to ORAOV1, BRCA and HPV-16 genes, mRNA associated to
IL-8 and many cancer related miRNAs), neurodegenerative diseases (PrPC proteins, Alzheimer-related
DNA sequences, mutated apolipoprotein E gene), bacterial (E. coli, Porphyromonas gingivalis 16S
rRNA, S. pneumoniae lytA gene Mycobacterium sp. genomic DNA, M. tuberculosis repetitive insertion
sequence IS6110 and rpoB gene, L. infantum genomic DNA, Leishmania DNA and S. haematobium
16S rRNA) and viral infections (DENV-3-specific DNA sequences, Hepatitis C viral DNA, HIV
antibodies and human norovirus). In particular, selected contributions describe the development of
versatile electrochemical nucleic acid based scaffolds for determining different levels of circulating
biomarkers mainly of genetic but also of protein nature. The compiled approaches are based on
the use of conventional electrodes (gold, GCE, ITO, PGE), arrays of gold electrodes prepared by
photolithography or disposable electrodes (SPCEs, Au-SPEs), different bioreceptors, mainly linear and
hairpin DNAs but also RNA probes, aptamers and peptides, amplification strategies (“junction-probe”
isothermal amplification, nuclease-assisted target recycling, formation of long-range self-assembled
DNA nanostructures, RCA, RPA, enzymatic and nanomaterials-based amplification) and a wide variety
of electrochemical techniques including (chorono) amperometry, DPV, SWV, EIS, DPV, CV, LSV and
ACV. The determinations of the circulating biomarkers with electrochemical genosensors have been
performed mainly in serum, saliva, plasma, and urine samples. It is worth mentioning at this point
that the choice of an electrochemical technique in the highlighted approaches is closely related with
particular variables like the selected electrochemical label and the assay format, as well as, of course,
the target analyte and sample matrix. Therefore, although experience in this field could help in some
way, the wide variability of available electrochemical techniques makes it difficult to recommend
a priori the most appropriate and selection should be made depending on the particular application
and only by experimental testing.
By the number of strategies described so far in this field, the determination of circulating
biomarkers associated with cancer and bacterial and viral infections have gained special relevance in
this field, and the use of sandwich hybridization formats followed by direct approaches both involving
DNA linear probes are by far the most common strategies. Other less common but very attractive
approaches are based on the use of TRE assays.
In parallel with remarkable progress in nanotechnology and bioconjugation techniques, some
of these electrochemical genosensing strategies have been developed onto nanostructured surfaces
using graphene, graphene oxide, mesoporous nanomaterials, AuNRs and MWCNTs and/or using
bioconjugates of AuNPs with multiple bioreceptors as signaling carriers. Dendrimers such as PAMAN
G4 and polymers (PPy, PANI) have been also used also as electrode modifiers to improve the
performance of these electrochemical genosensors for circulating biomarkers determination. Moreover,
these approaches have been developed both using integrated formats and by coupling conveniently
modified MBs with SPEs or magnetic-conventional electrodes.
The developed electrochemical genosensors have demonstrated to detect protein and genetic
biomarkers in the 0.5 pM–1 nM and 1 aM–3.09 nM ranges, respectively, depending of each application
but all of them have demonstrated to be suitable for practical purposes through the analysis of
real samples.
5. Challenges to Address and Future Prospects
Nowadays healthcare systems are pursuing the development of cheap, rapid, non-invasive and
user-friendly tools able to provide multiple results from a single sample even in remote settings to help
in the timely decision-making. Moreover, the use of information and communication technologies in
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healthcare (e-health) to improve diagnosis, treatment, monitoring and management is also stimulating
the research and the development of portable devices for patient-monitoring.
In this sense, electrochemical genosensing has clearly been gaining increasing relevance in
the clinical analysis field using non-invasive approaches, such as the determination of circulating
biomarkers. The resulting devices can be portable, easy-to-use, with rapid response times, affordable
and easily tailored for the needs of low- and middle-income countries.
Although exhaustive literature evaluation shows there is a large number of electrochemical nucleic
acid-based biosensors able to comply with the sensitivity and selectivity demanded for practical
applications, most of them still remain in the proof of concept or prototype stages of development
and only a limited number (those highlighted in this review) have demonstrated applicability in the
analysis of real non- or minimally invasive samples (mainly serum, urine and saliva). However, it
is worth to mention also that the number of real patient samples used in these methods is never
enough to assure a reliable validation of the genosensor and that currently only a very limited
number of circulating biomarkers have been clinically validated. The compulsory validation of these
electrochemical genosensing devices using large numbers of patient samples must be performed not
only in terms of sensitivity, selectivity and accuracy, but also of rapidity, simplicity and cost with
respect to other available competitive methodologies.
It is worth to mention in this point that despite the tremendous progress made in the latest years
and the very promising capabilities already demonstrated for circulating biomarkers determination,
unfortunately the transition of electrochemical genosensors from laboratories to the market is
complicated and none has crossed the technological valley of death to successful commercialization.
The translation of current research prototypes into commercial products should mainly address some
quality assurance challenges. One of the most critical aspects to be solved is the achievement of
reproducible quantitative results which depends both of the feasibility of producing identical sensor
batches and of the control of environmental variables which can affect significantly their performance.
A second aspect to be tackled relates with the difficulty on developing simple-to-use assays for
non-laboratory trained individuals, more prone than competent staff in well-run laboratories to
making mistakes.
Moreover, to achieve the commonly accepted usage of electrochemical genosensors for POC
testing, additional research efforts are needed toward their full integration in automated and
miniaturized systems. Currently, the complicated assembly process of the genosensors and their
subsequent scaling up to mass production makes the manufacturing of commercially available
devices challenging and expensive. Other challenges crucial for commercialization prospects include
ensuring the storage stability of the prepared nucleic acid-based bioplatforms and the bioconjugates
of nanomaterials used commonly for amplification purposes and their transportation conditions for
appropriate functionality.
Therefore, further efforts on genosensor stability and validation, together with their continuous
miniaturization and automatization, are key steps to ensure their successful use in POC testing for
making clinical results available at patient bedside or physician office. One cannot fail to mention
that additional challenge in electrochemical genosensing continue being the reliable, simultaneous
detection of multiple circulating biomarkers and proper attention to the nonspecific adsorption issues
in complex biological samples.
Although the important and complex challenges to be addressed makes it likely that several years
will pass before electrochemical genosensing devices will fully replace techniques currently used for
circulating biomarker routine determinations, the electrochemical genosensing diagnostic platforms
are eliciting considerable excitement as they promise a paradigmatic shift in how disease diagnosis
and health monitoring will be conducted in the near future. The development and deployment
of these systems could ultimately lead to more rapid clinical decision making and corresponding
reductions in patient stress and healthcare costs. Moreover, it is undoubtedly that with constant
developments in molecular biology, nanofabrication methods and labeling, nanoinstrumentation, and
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multiplexing capabilities, rapid, sensitive, selective, and easy-to-use electrochemical genosensors will
find an important niche for circulating biomarkers determinations in the clinical field.
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daPCR direct asymmetric PCR
DENV-3 dengue virus serotype 3
DNS duplex specific nuclease
DPV differential pulse voltammetry
ds double-stranded
DSNATR duplex-specific nuclease assisted target recycling
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
EGFR epidermal growth factor receptor
EIS electrochemical impedance spectroscopy
ELISAs enzyme linked immunosorbent assays
Fc ferrocene
FITC fluorescein isothiocyanate
GCE glassy carbon electrode
GO graphene oxide
GSHs graphene and mesoporous hybrid nanomaterials
HDA helicase-dependent DNA amplification
HER hydrogen evolution reaction









MSGNs graphene and mesoporous multifunctional hybrids materials
MWCNTs multi-walled carbon nanotubes
NHS N-hydroxysuccinimide
NSCLC non-small cell lung carcinoma
PAMAM polyamidoamine
PANI polyaniline
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PCR polymerase chain reaction
Pg Porphyromonas gingivalis
PGE pencil graphite electrode
POC point-of-care
POCT POC tests
PrPC human cellular prions
Py pyrrole
RPA isothermal recombinase polymerase amplification
SAM self-assembled monolayer
SDA strand displacement amplification
Sp signaling probe
SPEs screen-printed electrodes
SPCEs screen-printed carbon electrodes
ss single-stranded
Strep-HRP streptavidin-peroxidase
SWV square wave voltammetry
TMB 3,3′,5,5′ tetramethylbenzidine
TSEs transmissible spongiform encephalopathies
TTF tetrathiafulvalene
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